BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29189063)

  • 21. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
    Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
    Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
    Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
    Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.
    Klöppel G; Lüttges J
    Curr Gastroenterol Rep; 2004 Apr; 6(2):111-8. PubMed ID: 15191688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification, morphology and molecular pathology of premalignant lesions of the pancreas.
    Cooper CL; O'Toole SA; Kench JG
    Pathology; 2013 Apr; 45(3):286-304. PubMed ID: 23442735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precursor Lesions of Pancreatic Cancer.
    Kim JY; Hong SM
    Oncol Res Treat; 2018; 41(10):603-610. PubMed ID: 30269131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and analysis of precursors to invasive pancreatic cancer.
    Matthaei H; Dal Molin M; Maitra A
    Methods Mol Biol; 2013; 980():1-12. PubMed ID: 23359146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
    Andea A; Sarkar F; Adsay VN
    Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
    Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R
    Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraductal papillary mucinous tumors and mucinous cystic tumors of the pancreas: imaging.
    Choe KA
    J Hepatobiliary Pancreat Surg; 2003; 10(2):137-41. PubMed ID: 14505146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.
    Ren B; Liu X; Suriawinata AA
    Am J Pathol; 2019 Jan; 189(1):9-21. PubMed ID: 30558727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
    Katabi N; Klimstra DS
    J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].
    Ledniczky G; Bognár G; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):22-6. PubMed ID: 19218165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic intraepithelial neoplasia revisited and updated.
    Sipos B; Frank S; Gress T; Hahn S; Klöppel G
    Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.